High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Sargos, Paul ^a,b   Dejean, Catherine ^a   Figueiredo, Bénédicte Henriques de ^a,b   Brouste, Véronique ^a   Nguyen Bui, Binh ^a   Italiano, Antoine ^a,b   Stoeckle, Eberhard ^a   Kantor, Guy ^a,b  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Helical tomotherapy; Intensity modulated radiotherapy; Liposarcoma; Pre operative radiotherapy; Retroperitoneal sarcoma; Surgery

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL ARTICLE; DIARRHEA; DOSIMETRY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIPOSARCOMA; MALE; NAUSEA AND VOMITING; PARESTHESIA; POSTOPERATIVE PERIOD; PREOPERATIVE HELICAL TOMOTHERAPY; PREOPERATIVE RADIOTHERAPY; RETROSPECTIVE STUDY; TOMOTHERAPY; TREATMENT DURATION; TREATMENT PLANNING;

ADULT; AGED; FEASIBILITY STUDIES; FEMALE; HUMANS; LIPOSARCOMA; MALE; MIDDLE AGED; PREOPERATIVE CARE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROPERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84871013884     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-214     Document Type: Article

References (25)

1. Catton CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y, Fornasier V. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994, 29:1005-1010. 10.1016/0360-3016(94)90395-6, 8083069.
2. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998, 228:355-365. 10.1097/00000658-199809000-00008, 1191491, 9742918.
3. Bonvalot S, Vanel D, Le Cesne A, Terrier P, Le Pechoux C. Surgery of retroperitoneal sarcomas. Cancer Radiother 2006, 10:41-49. 10.1016/j.canrad.2005.09.028, 16300983.
4. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, Laplanche A. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009, 27:31-37. 10.1200/JCO.2008.21.0963, 19047280.
5. Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, Lozza L, Pennacchioli E, Mariani L, Casali PG. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009, 27:24-30. 10.1200/JCO.2008.21.0351, 19047283.
6. Musat E, Kantor G, Caron J, Lagarde P, Laharie H, Stoeckle E, Angles J, Gilbeau L, Bui BN. Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma. Cancer Radiother 2004, 8:255-261. 10.1016/j.canrad.2004.05.001, 15450519.
7. Tzeng CW, Fiveash JB, Popple RA, Arnoletti JP, Russo SM, Urist MM, Bland KI, Heslin MJ. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006, 107:371-379. 10.1002/cncr.22005, 16752414.
8. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986, 58:306-309. 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO;2-7, 3719523.
9. Martin E, Pointreau Y, Roche-Forestier S, Barillot I. Normal tissue tolerance to external beam radiation therapy: small bowel. Cancer Radiother 2010, 14:350-353. 10.1016/j.canrad.2010.03.013, 20598616.
10. Kantor G, Mahe MA, Giraud P, Alapetite C, Durdux C, Fourquet A, Gardner M, Le Prise E, Maire JP, Richaud P, et al. French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins. Cancer Radiother 2007, 11:331-337. 10.1016/j.canrad.2007.09.006, 17962061.
11. Kantor G, Mahe MA, Giraud P, Lisbona A, Caron J, Mazal A. [Helical tomotherapy: general methodology for clinical and dosimetric evaluation (national French project)]. Cancer Radiother 2006, 10:488-491. 10.1016/j.canrad.2006.09.037, 17055315.
12. D'Souza WD, Rosen II. Nontumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003, 30:2065-2071. 10.1118/1.1591991, 12945972.
13. Youssef E, Fontanesi J, Mott M, Kraut M, Lucas D, Mekhael H, Ben-Josef E. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys 2002, 54:514-519. 10.1016/S0360-3016(02)02942-5, 12243830.
14. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001, 92:359-368. 10.1002/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y, 11466691.
15. Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006, 13:508-517. 10.1245/ASO.2006.05.035, 16491338.
16. Zlotecki RA, Katz TS, Morris CG, Lind DS, Hochwald SN. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 2005, 28:310-316. 10.1097/01.coc.0000158441.96455.31, 15923806.
17. Bossi A, De Wever I, Van Limbergen E, Vanstraelen B. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys 2007, 67:164-170. 10.1016/j.ijrobp.2006.08.023, 17084556.
18. Gilbeau L, Kantor G, Stoeckle E, Lagarde P, Thomas L, Kind M, Richaud P, Coindre JM, Bonichon F, Bui BN. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 2002, 65:137-143. 10.1016/S0167-8140(02)00283-9, 12464441.
19. Tepper JE, Suit HD, Wood WC, Proppe KH, Harmon D, McNulty P. Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1984, 10:825-830. 10.1016/0360-3016(84)90383-3, 6735766.
20. Koshy M, Landry JC, Lawson JD, Staley CA, Esiashvili N, Howell R, Ghavidel S, Davis LW. Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction. Sarcoma 2003, 7:137-148. 10.1080/13577140310001644751, 2395528, 18521378.
21. Paumier A, Le Pechoux C, Beaudre A, Negretti L, Ferreira I, Roberti E, Brahim J, Lefkopoulos D, Daly-Schweitzer N, Bourhis J, Bonvalot S. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?. Radiother Oncol 2011, 99:73-78. 10.1016/j.radonc.2011.02.002, 21439664.
22. Wiezorek T, Schwahofer A, Schubert K. The Influence of Different IMRT Techniques on the Peripheral Dose. Strahlenther Onkol 2009, 185:696-702. 10.1007/s00066-009-2005-9, 19806336.
23. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88. 10.1016/S0360-3016(03)00073-7, 12694826.
24. Boda-Heggemann J, Lohr F, Wenz F, Flentje M, Guckenberger M. kV Cone-Beam CT-Based IGRT. Strahlenther Onkol 2011, 187:284-291. 10.1007/s00066-011-2236-4, 21533757.
25. Lisbona A, Averbeck D, Supiot S, Delpon G, Ali D, Vinas F, Diana C, Murariu C, Lagrange JL. IMRT combined to IGRT: increase of the irradiated volume. Consequences?. Cancer Radiother 2010, 14:563-570. 10.1016/j.canrad.2010.07.227, 20729117.